In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q4 2007

Executive Summary

Highlights from the Q4 2007 review of medical device and in vitro diagnostics/research dealmaking: there was a boost in medical device acquisitions--with patient monitoring in particular, which accounted for about half the total of this period--capping off an impressive year in medtech M&A activity. Of note in the in vitro diagnostics/research space was glucose monitoring, which brought in 60% of the total GM segment's $160 million in financing for the entire year.

Related Content

Continuous Glucose Monitoring: A Revolution Powered by DexCom
Taking Stock of Public Investor Interest in Device Companies
Continuous Glucose Monitoring: A Revolution Powered by DexCom
Trends for the New Year: Can Medtech Build on the Success of 2007?
Philips Homes In on Respironics: Fills Gaps in Care Continuum
Evalve, Mitralign Deals: Heart Valves Draw New Device Investors
Boston Scientific Shuffles and Sells in Bid to Right Ship
Inverness Buys Bulk
Evalve: Leading the Valve Revolution
Remote Patient Monitoring: The Markets Near and Far


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts